Price Andrew L
Chief Accounting Officer
- Shares
- 5,211
- Price
- $120.93
- Value
- $630,166
EHC
4 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$26,430,023
0 buyers · 4 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$47,785,597
6 distinct insiders
Highlighted alerts
19
0 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
EHC overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2026, Encompass Health paid a dividend on its common stock of $0.21 per share and the closing price was $127.77. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment. The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2025 to defer fixed percentages of their director fees for 2026. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the director's fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly fee deferral and the dividend of $0.21 per share paid on October 15, 2026. This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $126.62 to $126.73, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Voluntary purchases and sales; administrative noise stays hidden.
Price Andrew L
Chief Accounting Officer
Darby John Patrick
EVP, Gen Counsel & Secretary
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
Tarr Mark J
President & CEO
Tarr Mark J
President & CEO
Darby John Patrick
EVP, Gen Counsel & Secretary
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
Tuer Patrick William
EVP, Chief Operating Officer
Fay Edmund
Sr. Vice Pres. and Treasurer
Tarr Mark J
President & CEO
Tarr Mark J
President & CEO
Tarr Mark J
President & CEO
Tarr Mark J
President & CEO
Tarr Mark J
President & CEO
Tarr Mark J
President & CEO
Tarr Mark J
President & CEO
Tuer Patrick William
EVP, Chief Operating Officer
Tuer Patrick William
EVP, Chief Operating Officer
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Price Andrew L Chief Accounting Officer | Sale | 5,211 | $120.93 | $630,166 | |
| Aug 31, 2026 | Darby John Patrick EVP, Gen Counsel & Secretary | Sale | 4,858 | $121.09 | $588,255 | |
| Aug 10, 2026 | COLTHARP DOUGLAS E EVP & Chief Financial Officer | Sale | 18,869 | $125.38 | $2,365,795 | |
| Aug 10, 2026 | Tarr Mark J President & CEO | Sale | 1,579 | $126.06 | $199,049 | |
| Aug 10, 2026 | Tarr Mark J President & CEO | Sale | 171,569 | $125.46 | $21,525,047 | |
| Aug 10, 2026 | Darby John Patrick EVP, Gen Counsel & Secretary | Sale | 8,906 | $125.95 | $1,121,711 | |
| May 15, 2026 | COLTHARP DOUGLAS E EVP & Chief Financial Officer | Sale | 1 | $107.28 | $107.28 | |
| May 15, 2026 | COLTHARP DOUGLAS E EVP & Chief Financial Officer | Sale | 27,693 | $106.83 | $2,958,443 | |
| May 11, 2026 | Tuer Patrick William EVP, Chief Operating Officer | Sale | 682 | $104.56 | $71,310 | |
| Mar 09, 2026 | Fay Edmund Sr. Vice Pres. and Treasurer | Sale | 11,937 | $107.00 | $1,277,259 | |
| Feb 11, 2026 | Tarr Mark J President & CEO | Sale | 213 | $113.58 | $24,193 | |
| Feb 11, 2026 | Tarr Mark J President & CEO | Sale | 87,745 | $113.09 | $9,923,082 | |
| Feb 11, 2026 | Tarr Mark J President & CEO | Sale | 6,057 | $111.89 | $677,718 | |
| Feb 11, 2026 | Tarr Mark J President & CEO | Sale | 10,954 | $110.92 | $1,215,018 | |
| Feb 11, 2026 | Tarr Mark J President & CEO | Sale | 15,584 | $110.07 | $1,715,331 | |
| Feb 11, 2026 | Tarr Mark J President & CEO | Sale | 13,231 | $108.80 | $1,439,533 | |
| Feb 11, 2026 | Tarr Mark J President & CEO | Sale | 16,216 | $108.03 | $1,751,814 | |
| Feb 10, 2026 | Tuer Patrick William EVP, Chief Operating Officer | Sale | 2,804 | $107.62 | $301,766 | |
| Aug 27, 2025 | Tuer Patrick William EVP, Chief Operating Officer | Sale | 1,020 | $123.59 | $126,062 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.